Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance.

Park SY, Lee CJ, Choi JH, Kim JH, Kim JW, Kim JY, Nam JS.

J Exp Clin Cancer Res. 2019 Sep 11;38(1):399. doi: 10.1186/s13046-019-1405-7.

2.

Targeting Cancer Stem Cells in Triple-Negative Breast Cancer.

Park SY, Choi JH, Nam JS.

Cancers (Basel). 2019 Jul 9;11(7). pii: E965. doi: 10.3390/cancers11070965. Review.

3.

Antitumor and Apoptosis-inducing Effects of Piperine on Human Melanoma Cells.

Yoo ES, Choo GS, Kim SH, Woo JS, Kim HJ, Park YS, Kim BS, Kim SK, Park BK, Cho SD, Nam JS, Choi CS, Che JH, Jung JY.

Anticancer Res. 2019 Apr;39(4):1883-1892. doi: 10.21873/anticanres.13296.

PMID:
30952729
4.

Inhibition of LEF1-Mediated DCLK1 by Niclosamide Attenuates Colorectal Cancer Stemness.

Park SY, Kim JY, Choi JH, Kim JH, Lee CJ, Singh P, Sarkar S, Baek JH, Nam JS.

Clin Cancer Res. 2019 Feb 15;25(4):1415-1429. doi: 10.1158/1078-0432.CCR-18-1232. Epub 2018 Nov 16.

PMID:
30446587
5.

C-C motif chemokine receptor 1 (CCR1) is a target of the EGF-AKT-mTOR-STAT3 signaling axis in breast cancer cells.

Shin SY, Lee DH, Lee J, Choi C, Kim JY, Nam JS, Lim Y, Lee YH.

Oncotarget. 2017 Oct 10;8(55):94591-94605. doi: 10.18632/oncotarget.21813. eCollection 2017 Nov 7.

6.

Anti‑inflammatory effect of quercetin and galangin in LPS‑stimulated RAW264.7 macrophages and DNCB‑induced atopic dermatitis animal models.

Lee HN, Shin SA, Choo GS, Kim HJ, Park YS, Kim BS, Kim SK, Cho SD, Nam JS, Choi CS, Che JH, Park BK, Jung JY.

Int J Mol Med. 2018 Feb;41(2):888-898. doi: 10.3892/ijmm.2017.3296. Epub 2017 Nov 29.

7.

Strategies to Tackle Radiation Resistance by Penetrating Cancer Stem Cell Line of Scrimmage.

Park SY, Kim JY, Jun Y, Nam JS.

Recent Pat Anticancer Drug Discov. 2018;13(1):18-39. doi: 10.2174/1574892812666171003150410. Review.

PMID:
28971778
8.

Roles of Wnt Target Genes in the Journey of Cancer Stem Cells.

Kim JH, Park SY, Jun Y, Kim JY, Nam JS.

Int J Mol Sci. 2017 Jul 25;18(8). pii: E1604. doi: 10.3390/ijms18081604. Review.

9.

Anticancer effects of Ixeris dentata (Thunb. ex Thunb.) nakai extract on human melanoma cells A375P and A375SM.

Lee HN, Shin SA, Choo GS, Kim HJ, Park YS, Park BK, Kim BS, Kim SK, Cho SD, Nam JS, Choi CS, Jung JY.

J Ethnopharmacol. 2016 Dec 24;194:1022-1031. doi: 10.1016/j.jep.2016.11.010. Epub 2016 Nov 8.

PMID:
27836777
10.

HIF2α/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy.

Kwak JH, Lee NH, Lee HY, Hong IS, Nam JS.

Oncotarget. 2016 Jul 12;7(28):43518-43533. doi: 10.18632/oncotarget.9846.

11.

CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment.

Kim JY, Lee HY, Park KK, Choi YK, Nam JS, Hong IS.

Oncotarget. 2016 Apr 12;7(15):20395-409. doi: 10.18632/oncotarget.7954.

12.

The Wnt/β-catenin signaling/Id2 cascade mediates the effects of hypoxia on the hierarchy of colorectal-cancer stem cells.

Dong HJ, Jang GB, Lee HY, Park SR, Kim JY, Nam JS, Hong IS.

Sci Rep. 2016 Mar 11;6:22966. doi: 10.1038/srep22966.

13.

Peroxiredoxin II Is Essential for Maintaining Stemness by Redox Regulation in Liver Cancer Cells.

Kwon T, Bak Y, Park YH, Jang GB, Nam JS, Yoo JE, Park YN, Bak IS, Kim JM, Yoon DY, Yu DY.

Stem Cells. 2016 May;34(5):1188-97. doi: 10.1002/stem.2323. Epub 2016 Feb 25.

14.

TGF-β Type I Receptor Kinase Inhibitor EW-7197 Suppresses Cholestatic Liver Fibrosis by Inhibiting HIF1α-Induced Epithelial Mesenchymal Transition.

Kim MJ, Park SA, Kim CH, Park SY, Kim JS, Kim DK, Nam JS, Sheen YY.

Cell Physiol Biochem. 2016;38(2):571-88. doi: 10.1159/000438651. Epub 2016 Feb 5.

15.

TIMP-1 mediates TGF-β-dependent crosstalk between hepatic stellate and cancer cells via FAK signaling.

Park SA, Kim MJ, Park SY, Kim JS, Lim W, Nam JS, Yhong Sheen Y.

Sci Rep. 2015 Nov 9;5:16492. doi: 10.1038/srep16492.

16.

Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.

Park SY, Kim MJ, Park SA, Kim JS, Min KN, Kim DK, Lim W, Nam JS, Sheen YY.

Oncotarget. 2015 Nov 10;6(35):37526-43. doi: 10.18632/oncotarget.6063.

17.

Targeting cancer stem cells by using the nanoparticles.

Hong IS, Jang GB, Lee HY, Nam JS.

Int J Nanomedicine. 2015 Sep 10;10(Spec Iss):251-60. doi: 10.2147/IJN.S88310. eCollection 2015. Review.

18.

Spotlight on nano-theranostics in South Korea: applications in diagnostics and treatment of diseases.

Lee S, Kim J, Bark CW, Lee B, Ju H, Kang SC, Kim T, Kim MI, Ko YT, Nam JS, Yoon HH, Yun KS, Yoon YS, An SS, Hulme J.

Int J Nanomedicine. 2015 Aug 25;10 Spec Iss:3-8. doi: 10.2147/IJN.S91389. eCollection 2015.

19.

Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.

Jang GB, Kim JY, Cho SD, Park KS, Jung JY, Lee HY, Hong IS, Nam JS.

Sci Rep. 2015 Jul 23;5:12465. doi: 10.1038/srep12465.

20.

Convallaria keiskei as a novel therapeutic alternative for salivary gland cancer treatment by targeting myeloid cell leukemia-1.

Lee HE, Nam JS, Shin JA, Hong IS, Yang IH, You MJ, Cho SD.

Head Neck. 2016 Apr;38 Suppl 1:E761-70. doi: 10.1002/hed.24096. Epub 2015 Jul 15.

PMID:
25914292

Supplemental Content

Loading ...
Support Center